Moderate to Severe Asthma: Journal Articles

• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• COVID-19 and Pediatric Asthma: Friend or Foe? What do we currently know about the interplay between COVID-19 and asthma in children?
  Current Opinion in Allergy and Clinical Immunology, March 17, 2022
• Cost-Utility of Triple vs Dual Inhaler Therapy in Asthma Which of these treatment options for moderate to severe asthma is most cost-effective?
  BMC Pulmonary Medicine, February 10, 2022
• Severe Refractory Asthma Treated With Benralizumab Is benralizumab an effective alternative for severe eosinophilic asthma patients who did not respond to other biologic treatments?
  BMC Pulmonary Medicine, January 27, 2022
• Optimizing Inhalation Therapy in COPD and Asthma Patients Which strategies may help COPD or asthma patients achieve optimal inhalation flow rates?
  BMC Pulmonary Medicine, October 28, 2021
• The Effect of Curcumin in Moderate to Severe Asthmatics Are curcumin supplements beneficial in the management of patients with moderate to severe asthma?
  BMC Pulmonary Medicine, October 06, 2021
• Is Asthma a Risk Factor for COVID-19 Worse Outcomes? Evidence suggests that asthma patients may not have a higher risk for COVID-19 or worse outcomes, but optimizing asthma management during the pandemic is key.
  Current Opinion in Allergy and Clinical Immunology, May 17, 2021
• Spontaneous Resolution of Atopic Dermatitis With Benralizumab This patient experienced spontaneous resolution of atopic dermatitis while participating in a trial of benralizumab for severe asthma, highlighting the potential shared mechanisms of these conditions.
  Journal of Medical Case Reports, May 13, 2021
• Asthma, SARS-CoV-2 and COVID-19 What have we learned about the interaction between asthma and COVID-19? Might asthma medications have an impact on outcomes?
  Current Opinion in Allergy and Clinical Immunology, March 18, 2021
• Advances in Allergen Immunotherapy for Asthma What have we learned about the benefits of allergen immunotherapy as a therapeutic option for asthma?
  Current Opinion in Allergy and Clinical Immunology, November 12, 2020
• Asthma Care Quality, Language, and Ethnicity in Children Do Latino children experience disparities for their asthma care management compared to non-Hispanic white children?
  Journal of the American Board of Family Medicine, October 15, 2020
• Efficacy of Benralizumab for Severe Eosinophilic Asthma A new study evaluates the efficacy of benralizumab for severe eosinophilic asthma in a real-life setting.
  BMC Pulmonary Medicine, October 07, 2020
• Serum Prednisolone and Corticosteroid Adherence in Asthma Serum prednisolone measurements may be an effective means of monitoring adherence to oral corticosteroid treatment in severe asthma patients.
  BMC Pulmonary Medicine, September 23, 2020
• Real-Life Experience With Benralizumab During 6 Months Do the benefits of benralizumab therapy for severe asthma demonstrated in clinical trials translate into real-world clinical practice?
  BMC Pulmonary Medicine, August 14, 2020
• Mortality Among Adults With Both Asthma and COPD Do patients with features of both asthma and chronic obstructive pulmonary disease have worse health outcomes than those with asthma or COPD alone?
  Morbidity & Mortality Weekly Report, July 27, 2020
• Outcomes and Lung Function in Children With Severe Asthma What have we learned about outcomes and lung function among children with uncontrolled severe asthma?
  BMC Pulmonary Medicine, May 06, 2020
• Home Visits for Children With Asthma Reduce Medicaid Costs The READY study evaluated the effect and the cost benefits of a community health worker-led home intervention on improving outcomes for Medicaid-enrolled children with uncontrolled asthma.
  Preventing Chronic Disease, April 06, 2020
• Age-Specific Incidence of Allergic and Non-Allergic Asthma A new study looks at the incidence of asthma among children and adults by evaluating age at onset and the role of childhood allergies.
  BMC Pulmonary Medicine, February 28, 2020
• Indoor Environmental Control Among Children With Asthma Indoor environmental control practices are effective in reducing asthma symptoms among children. How do these practices differ by race/ethnicity in households with children with asthma in the US?
  Preventing Chronic Disease, January 27, 2020
• Asthma/Obstructive Pulmonary Disease Overlap What is asthma/COPD overlap and how should it be treated? A new review discusses the identification and management of this condition.
  Current Opinion in Allergy and Clinical Immunology, January 10, 2020